missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mouse CXCR2/IL-8RB Antibody, R&D Systems™

Rat Monoclonal Antibody has been used in 33 publications
Brand: R&D Systems MAB2164-500
This item is not returnable.
View return policy
Descripción
CXCR2/IL-8RB Monoclonal specifically detects CXCR2/IL-8RB in Mouse samples. It is validated for Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF-reported.
Especificaciones
| CXCR2/IL-8RB | |
| Monoclonal | |
| LYOPH | |
| Flow Cytometry 0.25 ug/10^6 cells, Neutralization 15-50 ug/mL, CyTOF-reported | |
| P35343 | |
| CXCR2 | |
| C6 rat glioma cell line transfected with mouse CXCR2 Met1-Leu359 Accession # P35343 | |
| 500 μg | |
| Primary | |
| Stains mouse CXCR2 transfected cells but not CXCR1 transfectants. | |
| Mouse | |
| IgG2a |
| Flow Cytometry, Neutralization, CyTOF | |
| 242216 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CD182, CD182 antigen, CDw128b, chemokine (C-X-C motif) receptor 2, chemokine (CXC) receptor 2, CMKAR2, C-X-C chemokine receptor type 2, CXC-R2, CXCR-2, CXCR2 gene for IL8 receptor type B, GRO/MGSA receptor, High affinity interleukin-8 receptor B, IL-8 RB, IL-8 receptor type 2, IL-8R B, IL8R2, IL8RA, IL8RB, interleukin 8 receptor B, interleukin 8 receptor type 2, interleukin-8 receptor type B | |
| Rat | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 3579 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido